The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource.
×
TSP48677-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to DBeQ TSA201131-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ TSA201172-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ TSA201217-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ TSA201259-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ TSA201303-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ TSA201348-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ TSA201386-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ TSA201421-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ TSF418175-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 3.33 µM for 24.0 h 1 subfactor(s) TSF418176-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 1.11 µM for 24.0 h 1 subfactor(s) TSF418174-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 10.0 µM for 24.0 h 1 subfactor(s) TSF418177-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 0.37 µM for 24.0 h 1 subfactor(s) TSF418178-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 0.125 µM for 24.0 h 1 subfactor(s) TSF418179-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 0.04 µM for 24.0 h 1 subfactor(s) TSF418462-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 1.11 µM for 24.0 h 1 subfactor(s) TSF418460-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 10.0 µM for 24.0 h 1 subfactor(s) TSF418463-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 0.37 µM for 24.0 h 1 subfactor(s) TSF418461-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 3.33 µM for 24.0 h 1 subfactor(s) TSF418464-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 0.125 µM for 24.0 h 1 subfactor(s) TSF418465-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 0.04 µM for 24.0 h 1 subfactor(s) TSF418753-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 0.04 µM for 24.0 h 1 subfactor(s) TSF418748-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 10.0 µM for 24.0 h 1 subfactor(s) TSF418749-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 3.33 µM for 24.0 h 1 subfactor(s) TSF418750-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 1.11 µM for 24.0 h 1 subfactor(s) TSF418751-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 0.37 µM for 24.0 h 1 subfactor(s) TSF418752-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 0.125 µM for 24.0 h 1 subfactor(s) TSF419035-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 10.0 µM for 24.0 h 1 subfactor(s) TSF419036-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 3.33 µM for 24.0 h 1 subfactor(s) TSF419037-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 1.11 µM for 24.0 h 1 subfactor(s) TSF419038-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 0.37 µM for 24.0 h 1 subfactor(s) TSF419039-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 0.125 µM for 24.0 h 1 subfactor(s) TSF419040-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 0.04 µM for 24.0 h 1 subfactor(s) TSF419326-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 1.11 µM for 24.0 h 1 subfactor(s) TSF419324-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 10.0 µM for 24.0 h 1 subfactor(s) TSF419325-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 3.33 µM for 24.0 h 1 subfactor(s) TSF419327-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 0.37 µM for 24.0 h 1 subfactor(s) TSF419328-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 0.125 µM for 24.0 h 1 subfactor(s) TSF419329-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 0.04 µM for 24.0 h 1 subfactor(s) TSF419617-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 0.37 µM for 24.0 h 1 subfactor(s) TSF419614-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 10.0 µM for 24.0 h 1 subfactor(s) TSF419615-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 3.33 µM for 24.0 h 1 subfactor(s) TSF419616-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 1.11 µM for 24.0 h 1 subfactor(s) TSF419618-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 0.125 µM for 24.0 h 1 subfactor(s) TSF419619-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 0.04 µM for 24.0 h 1 subfactor(s) TSF419907-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 0.125 µM for 24.0 h 1 subfactor(s) TSF419903-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 10.0 µM for 24.0 h 1 subfactor(s) TSF419908-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 0.04 µM for 24.0 h 1 subfactor(s) TSF419904-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 3.33 µM for 24.0 h 1 subfactor(s) TSF419905-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 1.11 µM for 24.0 h 1 subfactor(s) TSF419906-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 0.37 µM for 24.0 h 1 subfactor(s) TSF420179-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 0.37 µM for 24.0 h 1 subfactor(s) TSF420176-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 10.0 µM for 24.0 h 1 subfactor(s) TSF420177-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 3.33 µM for 24.0 h 1 subfactor(s) TSF420178-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 1.11 µM for 24.0 h 1 subfactor(s) TSF420180-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 0.125 µM for 24.0 h 1 subfactor(s) TSF420181-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 0.04 µM for 24.0 h 1 subfactor(s) TSS418183-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 3.33 µM for 24.0 h TSS418184-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 1.11 µM for 24.0 h TSS418182-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 10.0 µM for 24.0 h TSS418185-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 0.37 µM for 24.0 h TSS418186-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 0.125 µM for 24.0 h TSS418187-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to DBeQ 0.04 µM for 24.0 h TSS418470-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 1.11 µM for 24.0 h TSS418468-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 10.0 µM for 24.0 h TSS418471-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 0.37 µM for 24.0 h TSS418469-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 3.33 µM for 24.0 h TSS418472-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 0.125 µM for 24.0 h TSS418473-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to DBeQ 0.04 µM for 24.0 h TSS418761-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 0.04 µM for 24.0 h TSS418756-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 10.0 µM for 24.0 h TSS418757-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 3.33 µM for 24.0 h TSS418758-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 1.11 µM for 24.0 h TSS418759-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 0.37 µM for 24.0 h TSS418760-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to DBeQ 0.125 µM for 24.0 h TSS419043-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 10.0 µM for 24.0 h TSS419044-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 3.33 µM for 24.0 h TSS419045-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 1.11 µM for 24.0 h TSS419046-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 0.37 µM for 24.0 h TSS419047-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 0.125 µM for 24.0 h TSS419048-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to DBeQ 0.04 µM for 24.0 h TSS419334-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 1.11 µM for 24.0 h TSS419332-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 10.0 µM for 24.0 h TSS419333-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 3.33 µM for 24.0 h TSS419335-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 0.37 µM for 24.0 h TSS419336-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 0.125 µM for 24.0 h TSS419337-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to DBeQ 0.04 µM for 24.0 h TSS419625-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 0.37 µM for 24.0 h TSS419622-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 10.0 µM for 24.0 h TSS419623-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 3.33 µM for 24.0 h TSS419624-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 1.11 µM for 24.0 h TSS419626-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 0.125 µM for 24.0 h TSS419627-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to DBeQ 0.04 µM for 24.0 h TSS419915-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 0.125 µM for 24.0 h TSS419911-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 10.0 µM for 24.0 h TSS419916-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 0.04 µM for 24.0 h TSS419912-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 3.33 µM for 24.0 h TSS419913-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 1.11 µM for 24.0 h TSS419914-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to DBeQ 0.37 µM for 24.0 h TSS420187-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 0.37 µM for 24.0 h TSS420184-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 10.0 µM for 24.0 h TSS420185-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 3.33 µM for 24.0 h TSS420186-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 1.11 µM for 24.0 h TSS420188-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 0.125 µM for 24.0 h TSS420189-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to DBeQ 0.04 µM for 24.0 h
TSP48677 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to DBeQ
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided